QSAM Biosciences Signs Term Sheet to be Acquired by Telix Pharmaceuticals;
QSAM Biosciences Signs Term Sheet to be Acquired by Telix Pharmaceuticals; Receives $2 Million Pre-Closing Collaboration and Option Fee...
QSAM Biosciences Signs Term Sheet to be Acquired by Telix Pharmaceuticals;
Elucid Raises $80 Million in Series C Round Led by Elevage Medical Technologies
NeuroSigma Announces FDA 510(k) Submission for Second Generation Monarch eTNS System
NeuroSigma Announces HSA Approval of the Monarch eTNS System in Singapore
Bredis Healthcare Awarded South Korean Government Grant
Lactiga Receives FDA 'Rare Pediatric Disease' Designation
Austrianova and ProAgni sign license and manufacturing agreement
NeuroSigma Establishes Singapore Subsidiary